• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-甲基-D-天冬氨酸受体:从基因到通道

NMDA receptors: from genes to channels.

作者信息

Sucher N J, Awobuluyi M, Choi Y B, Lipton S A

机构信息

Laboratory of Cellular and Molecular Neuroscience, Children's Hospital, Boston, MA, USA.

出版信息

Trends Pharmacol Sci. 1996 Oct;17(10):348-55.

PMID:8979769
Abstract

N-methyl-D-aspartate receptors belong to the family of ionotropic glutamate receptors. NMDA receptors were named after the specific glutamate-like synthetic agonist N-methyl-D-aspartate. In the past decade, an increasing number of functional sites have been discovered and used to refine the operational definition of NMDA receptors. The goal to characterize the molecular substrate underlying the heretofore strictly operationally defined NMDA receptors has come into reach following the cloning of a number of cDNAs coding for NMDA receptor subunits. However, in their review, Nikolaus Sucher and colleagues show that caution should be exercised in comparing the pharmacological properties of recombinant NMDA receptors to those of native neurones. Future work on NMDA receptors will be challenged to reconcile disparate effects obtained with recombinant versus native receptors.

摘要

N-甲基-D-天冬氨酸受体属于离子型谷氨酸受体家族。NMDA受体以特定的谷氨酸样合成激动剂N-甲基-D-天冬氨酸命名。在过去十年中,已发现越来越多的功能位点,并用于完善NMDA受体的操作性定义。随着多个编码NMDA受体亚基的cDNA的克隆,表征迄今为止严格通过操作性定义的NMDA受体的分子底物的目标已经实现。然而,Nikolaus Sucher及其同事在综述中指出,在比较重组NMDA受体与天然神经元的药理学特性时应谨慎。NMDA受体的未来研究将面临协调重组受体与天然受体所产生的不同效应的挑战。

相似文献

1
NMDA receptors: from genes to channels.N-甲基-D-天冬氨酸受体:从基因到通道
Trends Pharmacol Sci. 1996 Oct;17(10):348-55.
2
Inducible expression and pharmacological characterization of recombinant rat NR1a/NR2A NMDA receptors.重组大鼠NR1a/NR2A N-甲基-D-天冬氨酸受体的诱导表达及药理学特性
Neurochem Int. 2005 Apr;46(5):369-79. doi: 10.1016/j.neuint.2004.12.002.
3
Synthesis and pharmacological evaluation of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methylguanidines as N-methyl-D-aspartate receptor ion-channel blockers.N-(2,5-二取代苯基)-N'-(3-取代苯基)-N'-甲基胍作为N-甲基-D-天冬氨酸受体离子通道阻滞剂的合成与药理评价
J Med Chem. 1997 Dec 19;40(26):4281-9. doi: 10.1021/jm970459c.
4
Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.通过定点诱变和分子建模确定的重组NR1/NR2A N-甲基-D-天冬氨酸受体中谷氨酸结合位点的结构特征。
Mol Pharmacol. 2005 May;67(5):1470-84. doi: 10.1124/mol.104.008185. Epub 2005 Feb 9.
5
N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents.N-甲基-D-天冬氨酸受体:谷氨酸拮抗剂、甘氨酸拮抗剂及通道阻滞剂结合所需的不同亚基
Mol Pharmacol. 1994 Mar;45(3):540-5.
6
Effect of agmatine on heteromeric N-methyl-D-aspartate receptor channels.胍丁胺对异聚体N-甲基-D-天冬氨酸受体通道的影响。
Neurosci Res. 2005 Aug;52(4):387-92. doi: 10.1016/j.neures.2005.05.002.
7
Physiology and pathology of NMDA receptors.NMDA受体的生理学与病理学
Prague Med Rep. 2005;106(2):113-36.
8
Comparative pharmacology of the human NMDA-receptor subtypes R1-2A, R1-2B, R1-2C and R1-2D using an inducible expression system.利用可诱导表达系统研究人 NMDA 受体亚基 R1-2A、R1-2B、R1-2C 和 R1-2D 的比较药理学。
Eur J Pharmacol. 2010 Jul 10;637(1-3):46-54. doi: 10.1016/j.ejphar.2010.04.002. Epub 2010 Apr 13.
9
Engineering the NMDA receptor channel lining.
Methods Mol Biol. 1999;128:167-78. doi: 10.1385/1-59259-683-5:167.
10
Neurosteroid modulation of N-methyl-D-aspartate receptors: molecular mechanism and behavioral effects.神经甾体对 N-甲基-D-天冬氨酸受体的调制:分子机制与行为效应。
Steroids. 2011 Dec 11;76(13):1409-18. doi: 10.1016/j.steroids.2011.09.002. Epub 2011 Sep 7.

引用本文的文献

1
Drug Development for Alzheimer's and Parkinson's Disease: Where Do We Go Now?阿尔茨海默病和帕金森病的药物研发:我们如今何去何从?
Pharmaceutics. 2024 May 24;16(6):708. doi: 10.3390/pharmaceutics16060708.
2
Diagnosis and Treatment of Alzheimer's Disease:: An Update.阿尔茨海默病的诊断与治疗:最新进展
Dela J Public Health. 2021 Sep 27;7(4):74-85. doi: 10.32481/djph.2021.09.009. eCollection 2021 Sep.
3
Synaptic Plasticity and its Modulation by Alcohol.突触可塑性及其受酒精的调节
Brain Plast. 2020 Dec 29;6(1):103-111. doi: 10.3233/BPL-190089.
4
Aerobic Exercise Prevents Depression via Alleviating Hippocampus Injury in Chronic Stressed Depression Rats.有氧运动通过减轻慢性应激抑郁大鼠的海马损伤来预防抑郁
Brain Sci. 2020 Dec 23;11(1):9. doi: 10.3390/brainsci11010009.
5
Less NMDA Receptor Binding in Dorsolateral Prefrontal Cortex and Anterior Cingulate Cortex Associated With Reported Early-Life Adversity but Not Suicide.背外侧前额叶皮质和前扣带回皮质中 NMDA 受体结合减少与报告的早期生活逆境有关,但与自杀无关。
Int J Neuropsychopharmacol. 2020 May 27;23(5):311-318. doi: 10.1093/ijnp/pyaa009.
6
Effectiveness of Acupuncture for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis.针灸治疗阿尔茨海默病的疗效:一项更新的系统评价和荟萃分析。
Curr Med Sci. 2019 Jun;39(3):500-511. doi: 10.1007/s11596-019-2065-8. Epub 2019 Jun 17.
7
Calcium Signaling and Tissue Calcification.钙信号转导与组织钙化
Cold Spring Harb Perspect Biol. 2019 Oct 1;11(10):a035303. doi: 10.1101/cshperspect.a035303.
8
Memantine for dementia.美金刚用于治疗痴呆症。
Cochrane Database Syst Rev. 2019 Mar 20;3(3):CD003154. doi: 10.1002/14651858.CD003154.pub6.
9
PDI Knockdown Inhibits Seizure Activity in Acute Seizure and Chronic Epilepsy Rat Models via -Nitrosylation-Independent Thiolation on NMDA Receptor.通过对N-甲基-D-天冬氨酸受体进行非亚硝基化的硫醇化反应,PDI基因敲低抑制急性癫痫发作和慢性癫痫大鼠模型中的癫痫活动。
Front Cell Neurosci. 2018 Nov 22;12:438. doi: 10.3389/fncel.2018.00438. eCollection 2018.
10
PDI regulates seizure activity via NMDA receptor redox in rats.PDI 通过调节 NMDA 受体的氧化还原反应来控制大鼠的癫痫发作活动。
Sci Rep. 2017 Feb 15;7:42491. doi: 10.1038/srep42491.